Objective: To investigate the anti-arthritic activity of ethanolic extract of Caesalpinia pulcherrima (ECP) in adjuvant arthritic (AA) rat model induced by Freund's complete adjuvant (FCA). Methods: Thirty healthy albino rats were selected and randomly divided into five groups. Arthritis was induced by Freund's complete adjuvant (FCA) and then treated with ethanolic extract of Caesalpinia pulcherrima for 28 days. The various parameters like paw volume, haematological parameters (RBC, WBC, Hb and ESR), and radiological studies were assessed. Results: In FCA induced arthritic rats, there was significant increase in rat paw volume whereas both doses of ECP treated groups showed strong significant reduction in paw volume. The altered haematological parameters in the arthritic rats were significantly recovered to near normal by the treatment with ECP at the dose of 200 and 400 mg/kg. Further radiological studies revealed the anti-arthritic activity of ECP by preventing cartilage and bone destruction of the arthritic joints of AA rats. Conclusion: ECP has shown anti-arthritic activity with a significant decrease in paw volume and it could significantly normalize the haematological abnormalities in adjuvant induced arthritic rats. Further radiological studies confirmed the anti-arthritic activity of ECP.
INTRODUCTION
Rheumatoid arthritis (RA) is a chronic, systemic autoimmune disorder that is associated with symmetrical, inflammatory polyarthritis that may produce progressive joint damage.
the release of toxic substances in the synovium that leads to cartilage destruction. 1 NSAIDS, Disease-Modifying Anti-Rheumatic Drugs (DMARDS), Biologic Response Modifiers and Corticosteroids are the most commonly used drugs for the treatment of RA. However, all of these agents are associated with numerous side effects. In present days, investigators are conducted towards traditional system of medicine for the exploration of drugs that are long acting anti-inflammatory with minimal side effects. The arthritis-like symptoms in AA rats share several histopathological features with human RA, including mononuclear cell infiltration and synoviocyte hyperplasia that results in pannus formation followed by bone and cartilage destruction. 2 The similarities in the joint pathology between rat arthritis and human RA are most widely used for studying the pathogenesis of human RA and for searching new drugs for RA management. Therefore, AA is most frequently used as a model for screening and testing anti-arthritic agents. 3 Caesalpinia pulcherrima is a medicinal plant belonging to the family Caesalpiniaceae. It is an ornamental plant due to its variety of flowers, which appear yellow, pink, off-white, and red with yellow margins. 4 Phytochemical studies made known the presence of pulcherrimin, terpenoids, sitosterol, flavonoids like quercetin and myricetin, carotenoids, glycosides, steroids, and phenols. 5 It is popular in Indian indigenous system of medicine like Siddha, Unani, Homoeopathy and Ayurveda. In traditional system of medicine, this plant has been used for anti-inflammatory, bronchitis, abortifacient, and malarial infection. 6 Although the plant possesses many potential therapeutic activities in traditional system and containing rich phytochemical constituents, no work has been still done about the antiarthritic activity. Taking these facts into considerations, the present study made an attempt to evaluate the antiarthritic activity of ethonolic extract of C. pulcherrima against freund's complete adjuvant induced arthritis in experimental rats.
MATERIALS AND METHODS

Plant material
The whole plant was collected from local area of kadapa, India. The plant product was authentified by Dr. K. Madava chetty, botanist, Department of Botany, SV University, Tirupathi, India. A voucher specimen (no.SV-30472) was deposited in the Department of Pharmacology, PRRM College of Pharmacy, Kadapa, India. The whole plant was shade dried and reduced mechanically to moderate coarse powder and stored in air tight vessel for further use.
Preparation of the extract
Extraction was done according to standard procedure using analytical grade solvents. The coarse powder of the whole plant (1 kg) was soxhlet extracted with 90% ethanol. The extract obtained was concentrated under vacuum to turnout ethanolic extract (18.70%). 
Experimental animals
Acute toxicity studies
Acute oral toxicity study of ethanolic extract of C. pulcherrima was performed in line with OECD guidelines 423.
Induction of arthritis
On day 0 rats were injected with 0.1 ml of FCA in to the sub plantar (s.p) region of the left hind paw of all the animals. This consists of Mycobacterium butyricum suspended in heavy paraffin oil by thoroughly grinding with a pestle and motor to give a final concentrate of 0.6 mg/mL. Administration of test compounds and standard drug was started on the next day and continued for 28 days.
Experimental set up
Total animals were randomly divided into five groups, each group containing 6 animals and treated for 28 days. The standard drug ibuprofen and ECP were suspended in 1% CMC with glass mortar, made as a suspension and administered immediately. Group I -Normal rats received distilled water; Group II-Arthritic rats administered CMC; Group III-Arthritic rats received ibuprofen 15 mg/kg, p.o. suspended in CMC; Group IV-Arthritic rats treated with ECP at dose of 200 mg/kg, p.o; Group V-Arthritic rats treated with ECP at dose of 400 mg/kg, p.o . The paw was marked with ink at the level of the malleolus laterials and paw volumes were recorded by the plethysmometer immediately after injection and on 7 th , 14 th , 21 st and 28 th day.
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Haematological screening
White blood cell (WBC) and Red blood cell (RBC) counts were assessed as stated in the method of Chesbrough and McArthur. 8 Drabkin and Austin method was used to confirming the Hemoglobin (Hb) content. 9 Estimation of erythrocyte sedimentation rate (ESR) was carried out by the method of Westergren.
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Radiographic analysis
X-ray images were taken for the affected paws of experimental rats, and checked for the soft swelling, bony erosions and narrowing of the spaces between joints. 
Data analysis
Results were analyzed using one way analysis of variance (ANOVA) followed by the tukey's test by using statistical software package, Graph Pad Prism; version 5.03. Values were expressed as mean ± SEM and the p <0.05 were considered as statistically significant.
RESULTS
Acute toxicity study
There was neither change in behavioral pattern or any sign of toxicity during the observations up to 24 h for mortality. The extracts were safe up to a maximum dose of 4000 mg/ kg. The biological evaluation was carried out at doses of 200 and 400 mg/kg.
Anti-arthritic activity
Effect of ECP on paw volume
Rats injected with FCA (group II) showed a significant increase in paw volume when compared to the normal rats (group I). Ethanolic extract treatment at the dose of 200 mg/kg and 400 mg/kg showed significant reduction in rat paw volume when compared with the group-II rats (Table 1 and Figure 1 ).
Effect of ECP on Haematological parameters
A significant reduce in the levels of Hb and RBC was observed in control rats (group II) when compared to normal rats (group I). Administration of ECP to diseased rats (group IV and group V) enhanced the levels of RBC and Hb to close normal levels. The raise in WBC count 
Figure 1: Effect of ECP on paw volume in arthritic rats
and ESR were significantly overcome in the extract treated groups (group IV and group V) ( Table 2) .
Radiographic analysis
The results were observed from X-ray was the normal group animals showed absence of soft tissue swelling and bony destruction. The arthritis control group animals was found with soft tissue swelling along with narrowing of joint spaces and sign of bony destruction. The treatment groups have shown prevention against bony destruction and narrowing of joint spaces by showing less soft tissue, swelling ( Figure 2 ).
DISCUSSION
Rheumatoid Arthritis is a common autoimmune disorder, the immunologically mediated FCA induced arthritic model is considered as one of the outstanding animal model of RA. FCA induced arthritis is an animal model of chronic polyarthritis with features that look like RA. 11 Determination of paw oedema is according to the grapevine simple, susceptible and rapid procedure for evaluate the degree of inflammation and assess the therapeutic effects of drugs. 12 In adjuvant-induced arthritic rats developed a chronic swelling in multiple joints with influence of inflammatory cells, erosion of joint cartilage and bone destruction and remodelling which have close similarity to human RA. These inflammatory changes eventually result in the complete destruction of joint stability and mobility in the arthritic rats. Also, soft tissue swelling around the ankle joints was appeared during the progress of arthritis in FCA injected rats, which was considered as oedema of the exacting tissues. 13 C. pulcherrima at doses of 200 and 400 mg/kg significantly and dose dependently inhibited paw swelling in arthritic rats.The cardinal signs of the chronic inflammatory reactions like swelling, redness, arthalgia and inactivity of affected joints were significantly less in the drug treated animal than those of the control rats.
In present study, arthritic control rats showed a reduced RBC count, reduced Hb levels, and an increased erythrocyte sedimentation rate (ESR). All these symptoms indicate an anemic condition.
14 The C. pulcherrima treated groups showed a significant recovery from the induced anemia. The significant increase in leukocyte count in adjuvantinduced arthritic rats may be due to the stimulation of immune system against the invading antigens and significant decrease in C. pulcherrima treated groups showed Radiographic changes in RA conditions are useful indicative measures which specify the severity of the disease. Soft tissue swelling is the earlier radiographic sign, whereas important radiographic changes like bony erosions and narrowing of joint spaces can be observed only in the developed stages of arthritis. 15 The radiographic features of the rat joints in adjuvant induced arthritic model are shown in Figure 2 . In adjuvant induced arthritic rat (group II), soft tissue swelling along with narrowing of the joint spaces were observed which implies the bony destruction in arthritic condition. The group receiving ECP at dose 400 mg/kg has shown significant prevention against bony destruction by showing less soft tissue swelling and narrowing of joint spaces when compared to arthritic control group.
Phytochemical investigations on C. pulcherrima have shown the presence pulcherrimin, terpenoids, sitosterol, lupeol, flavonoids like quercetin and myricetin, carotenoids, glycosides like sophorin, phenols, and steroids. 5 These components may exert its anti-inflammatory activity by inhibiting the 5-lipoxygenase pathway, which together with the COX-2 pathway, is very important in producing and maintaining inflammation. This previously has been shown to possess anti-inflammatory property of C. pulcherrima. 5 The presence of these compounds in the C. pulcherrima extract may explain the anti-arthritic properties of this plant. Taken together, our results strongly support the anti-arthritic potential of the plant C. pulcherrima and its use in traditional medicine.
CONCLUSION
The results obtained in this present study indicates that C. pulcherrima not only directs towards the control of arthritis progression and/or the inflammation associated with joint synovitis, but also prevents cartilage and bone destruction of the arthritic joints of AA rats. Hence, orally applicable C. pulcherrima, may have great potential as an alternative to the therapeutic agents currently available for treatment of RA.
